1887

Abstract

This report characterizes lentivirus attenuation associated with a mutation by inoculation of newborn kittens with a -deleted feline immunodeficiency virus provirus plasmid (FIV-pPPRΔvif). Virus in peripheral blood, antiviral antibody or CD4 T-cell count alterations were not detected in kittens inoculated with FIV-pPPRΔvif plasmid, with the exception of one kitten that demonstrated FIV Gag antibody production at 42 weeks after inoculation. In contrast, wild-type FIV-pPPR-infected kittens were viraemic, seropositive and exhibited a decrease in the CD4 T-cell subset in peripheral blood. Interestingly, FIV-specific T-cell proliferative responses detected at 32 and 36 weeks after infection were comparable for both FIV-pPPRΔvif- and wild-type FIV-pPPR-inoculated kittens and suggested the possibility of a discreet tissue reservoir supporting sustained FIV-pPPRΔvif expression or replication. Overall, these findings confirmed that the severe virus attenuation for both replication and pathogenicity exhibited by a -deleted FIV mutant is similar for both neonatal and adult hosts.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83268-0
2007-10-01
2021-10-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/10/2793.html?itemId=/content/journal/jgv/10.1099/vir.0.83268-0&mimeType=html&fmt=ahah

References

  1. Baba T. W., Jeong Y. S., Penninck D., Bronson R., Greene M. F., Ruprecht R. M. 1995; Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820–1825 [CrossRef]
    [Google Scholar]
  2. Baba T. W., Liska V., Khimani A. H., Ray N. B., Dailey P. J., Penninck D., Bronson R., Greene M. F., McClure H. M. other authors 1999; Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 5:194–203 [CrossRef]
    [Google Scholar]
  3. Barlough J. E., Ackley C. D., George J. W., Levy N., Acevedo R., Moore P. F., Rideout B. A., Cooper M. D., Pedersen N. C. 1991; Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquir Immune Defic Syndr 4:219–227
    [Google Scholar]
  4. Chakraborty R. 2005; HIV-1 infection in children: a clinical and immunologic overview. Curr HIV Res 3:31–41 [CrossRef]
    [Google Scholar]
  5. Cullen B. R. 2006; Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J Virol 80:1067–1076 [CrossRef]
    [Google Scholar]
  6. Dandekar S., Beebe A. M., Barlough J., Phillips T., Elder J., Torten M., Pedersen N. 1992; Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J Virol 66:4040–4049
    [Google Scholar]
  7. Dean G. A., Himathongkham S., Sparger E. E. 1999; Differential cell tropism of feline immunodeficiency virus molecular clones in vivo . J Virol 73:2596–2603
    [Google Scholar]
  8. Desrosiers R. C., Lifson J. D., Gibbs J. S., Czajak S. C., Howe A. Y. M., Arthur L. O., Johnson R. P. 1998; Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol 72:1431–1437
    [Google Scholar]
  9. Gabuzda D. H., Lawrence K., Langhoff E., Terwilliger E., Dorfman T., Haseltine W. A., Sodroski J. 1992; Role of vif in replication of human immunodeficiency virus type 1 in CD4+ lymphocytes. J Virol 66:6489–6495
    [Google Scholar]
  10. George J. W., Pedersen N. C., Higgins J. 1993; The effect of age on the course of experimental feline immunodeficiency virus infection. AIDS Res Hum Retroviruses 9:897–905 [CrossRef]
    [Google Scholar]
  11. Gupta S., Leutenegger C., Dean G., Sparger E. 2006; Construction and characterization of feline immunodeficiency proviral mutants that co-express interferon gamma and green fluorescent protein. AIDS Res Hum Retroviruses 22:342–349 [CrossRef]
    [Google Scholar]
  12. Gupta S., Leutenegger C. M., Dean G. A., Steckbeck J. D., Cole K. S., Sparger E. E. 2007; Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon. J Virol 81:465–473 [CrossRef]
    [Google Scholar]
  13. Harmache A., Russo P., Guiguen F., Vitu C., Vignoni M., Bouyac M., Hieblot C., Pepin M., Vigne R., Suzan M. 1996; Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 224:246–255 [CrossRef]
    [Google Scholar]
  14. Inoshima Y., Kohmoto M., Ikeda Y., Yamada H., Kawaguchi Y., Tomonaga K., Miyazawa T., Kai C., Umemura T., Mikami T. 1996; Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J Virol 70:8518–8526
    [Google Scholar]
  15. Kristbjornsdottir H. B., Andresdottir V., Svansson V., Torsteinsdottir S., Matthiasdottir S., Andresson O. S. 2004; The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro. Virology 318:350–359 [CrossRef]
    [Google Scholar]
  16. Lochelt M., Romen F., Bastone P., Muckenfuss H., Kirchner N., Kim Y. B., Truyen U., Rosler U., Battenberg M. other authors 2005; The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc Natl Acad Sci U S A 102:7982–7987 [CrossRef]
    [Google Scholar]
  17. Lockridge K. M., Himathongkham S., Sawai E. T., Chienand M., Sparger E. E. 1999; The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology 261:25–30 [CrossRef]
    [Google Scholar]
  18. Lockridge K. M., Chien M., Dean G. A., Stefano Cole K., Montelaro R. C., Luciw P. A., Sparger E. E. 2000; Protective immunity against feline immunodeficiency virus induced by inoculation with vif -deleted proviral DNA. Virology 273:67–79 [CrossRef]
    [Google Scholar]
  19. Marthas M. L., van Rompay K. K., Otsyula M. G., Miller C. J., Canfield D. R., Pedersen N. C., McChesney M. B. 1995; Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J Virol 69:4198–4205
    [Google Scholar]
  20. McChesney M. B., Collins J. R., Lu D., X., Torten J., Ashley R. L., Cloyd M. W., Miller C. J. 1998; Occult systemic infection and persistent SIV-specific CD4+ T cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 72:10029–10035
    [Google Scholar]
  21. Otsyula M. G., Miller C. J., Tarantal A. F., Marthas M. L., Greene T. P., Collins J. R., Van Rompay K. K., McChesney M. B. 1996; Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology 222:275–278 [CrossRef]
    [Google Scholar]
  22. Paul T. A., Casey J. W., Avery R. J., Sutton C. A. 2007; Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses. Virology 361:112–122 [CrossRef]
    [Google Scholar]
  23. Pedersen N. C., Leutenegger C. M., Woo J. C., Higgins J. 2001; Virulence differences between two field isolates in feline immunodeficiency virus (FIV-APetaluma and FIV-CpGammar) in young adult specific pathogen free cats. Vet Immunol Immunopathol 79:53–67 [CrossRef]
    [Google Scholar]
  24. Poeschla E. M., Wong-Staal F., Looney D. J. 1998; Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4:354–357 [CrossRef]
    [Google Scholar]
  25. Shacklett B. L., Luciw P. A. 1994; Analysis of the VIF gene of feline immunodeficiency virus. Virology 204:860–867 [CrossRef]
    [Google Scholar]
  26. Sheehy A. M., Gaddis N. C., Choi J. D., Malim M. H. 2002; Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646–650 [CrossRef]
    [Google Scholar]
  27. Sparger E. E., Beebe A. M., Dua N., Elder J., Himathongkam S., Torten M., Higgins J. 1994; Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology 205:546–553 [CrossRef]
    [Google Scholar]
  28. Sparger E. E., Ziomek A., Louie H., Luciw P. A. 1997; Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone. Virology 238:157–168 [CrossRef]
    [Google Scholar]
  29. Tasca S., Tsai L., Trunova N., Gettie A., Saifuddin M., Bohm R., Chakrabarti L., Cheng-Mayer C. 2007; Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure. Virology in press
    [Google Scholar]
  30. Tomonaga K., Norimine J., Shin Y., Fukasawa M., Miyazawa T., Adachi A., Toyosaki T., Kawaguchi Y., Kai C., Mikami T. 1992; Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J Virol 66:6181–6185
    [Google Scholar]
  31. Veazey R. S., Lifson J. D., Pandrea I., Purcell J., Piatak M., Lackner A. A. 2003; Simian immunodeficiency virus infection in neonatal macaques. J Virol 77:8783–8792 [CrossRef]
    [Google Scholar]
  32. von Gegerfelt A. S., Liska V., Li P. L., McClure H. M., Horie K., Nappi F., Montefiori D. C., Pavlakis G. N., Marthas M. L. other authors 2002; Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaques. J Virol 76:96–104 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83268-0
Loading
/content/journal/jgv/10.1099/vir.0.83268-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error